Jacques Robert
Jacques Robert
université de bordeaux
Verified email at
Cited by
Cited by
Multidrug resistance reversal agents
J Robert, C Jarry
Journal of medicinal chemistry 46 (23), 4805-4817, 2003
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
LP Rivory, MR Bowles, J Robert, SM Pond
Biochemical pharmacology 52 (7), 1103-1111, 1996
Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a …
E Gamelin, M Boisdron-Celle, V Guerin-Meyer, R Delva, A Lortholary, ...
Journal of Clinical Oncology 17 (4), 1105-1105, 1999
Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by …
E Gamelin, M Boisdron-Celle, R Delva, C Regimbeau, PE Cailleux, ...
Journal of Clinical Oncology 16 (4), 1470-1478, 1998
Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions
MC Haaz, L Rivory, C Riche, L Vernillet, J Robert
Cancer research 58 (3), 468-472, 1998
ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysisNER Gene …
M Yin, J Yan, E Martinez-Balibrea, F Graziano, HJ Lenz, HJ Kim, J Robert, ...
Clinical cancer research 17 (6), 1632-1640, 2011
Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture
S Bennis, C Chapey, J Robert, P Couvreur
European Journal of Cancer 30 (1), 89-93, 1994
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.
LP Rivory, MC Haaz, P Canal, F Lokiec, JP Armand, J Robert
Clinical cancer research: an official journal of the American Association …, 1997
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients
LP Rivory, JF Riou, MC Haaz, S Sable, M Vuilhorgne, A Commerçon, ...
Cancer Research 56 (16), 3689-3694, 1996
Pharmacokinetics and metabolism of anthracyclines.
J Robert, L Gianni
Cancer surveys 17, 219-252, 1993
Identification and kinetics of a β-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan
LP Rivory, J Robert
Cancer chemotherapy and pharmacology 36, 176-179, 1995
Kinetics of the in Vivo Interconversion of the Carboxylate and Lactone Forms of Irinotecan (CPT-11) and of Its Metabolite SN-38 in Patients
LP Rivory, E Chatelut, P Canal, A Mathieu-Boué, J Robert
Cancer research 54 (24), 6330-6333, 1994
DNA topoisomerase IIα expression and the response to primary chemotherapy in breast cancer
G MacGrogan, P Rudolph, I De Mascarel, L Mauriac, M Durand, A Avril, ...
British journal of cancer 89 (4), 666-671, 2003
Predicting drug response and toxicity based on gene polymorphisms
J Robert, V Le Morvan, D Smith, P Pourquier, J Bonnet
Critical reviews in oncology/hematology 54 (3), 171-196, 2005
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38
HM Dodds, MC Haaz, JF Riou, J Robert, LP Rivory
Journal of Pharmacology and Experimental Therapeutics 286 (1), 578-583, 1998
Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan …
LP Rivory, J Robert
Journal of Chromatography B: Biomedical Sciences and Applications 661 (1 …, 1994
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
E Gamelin, AL Bouil, M Boisdron-Celle, A Turcant, R Delva, A Cailleux, ...
Clinical cancer research: an official journal of the American Association …, 1997
Extraction of anthracyclines from biological fluids for HPLC evaluation
J Robert
Journal of Liquid Chromatography 3 (10), 1561-1572, 1980
Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research
A Vekris, D Meynard, MC Haaz, M Bayssas, J Bonnet, J Robert
Cancer research 64 (1), 356-362, 2004
Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response
J Robert, A Illiadis, B Hoerni, JP Cano, M Durand, C Lagarde
European Journal of Cancer and Clinical Oncology 18 (8), 739-745, 1982
The system can't perform the operation now. Try again later.
Articles 1–20